Recently, prothrombin gene mutation G20210A has been associated with elevat
ed thrombosis risk and rarely with cerebral vein thrombosis (CVT). Three pa
tients are described who had this genetic predisposition and who developed
CVT in an unusual constellation with other factors. In the first patient, t
he intake of valproic acid (VPA) may have played an aggravating role in the
development of CVT, in the second patient diagnosis of coagulation disorde
r was made during pregnancy consultation 6 years after CVT, in the third pa
tient the CVT occurred at the age of 78 years. In patients with CVT, coagul
ation-examinations should include tests for the prothrombin gene (G20210A)
mutation. (C) 2001 Elsevier Science B.V. All rights reserved.